Passkey Therapeutics

About Passkey Therapeutics

Passkey Therapeutics is a biotech company focused on unlocking biological complexity to discover better medicines. Their mission is to create new treatment options for patients with complex diseases by leveraging computational and experimental platforms to develop multifunctional therapeutics.

Products & Services

Synergistic Multifunctional Therapeutics (SMThs):A new class of drugs targeting Multilogs (rare combinations of proteins) to treat complex diseases in areas like cancer, autoimmune disorders, neurodegenerative disorders, and metabolic diseases.

Locksmith Platform:An integrated computational and experimental platform used to identify Multilogs and develop multifunctional drugs.

Specialties

Computational Drug Discovery Experimental Drug Discovery Multifunctional Therapeutics Targeting Multilogs Cancer Treatment Autoimmune Disorders Neurodegenerative Disorders Metabolic Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2024-10-22 FD: 2024-10-22	6 investors

Seed Latest

2024-10-22

$20.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Will Chen

Co-Founder, Chief Technology Officer

B

Bruce Beutel

Founder, CEO

S

Soumya Ray

Co-founder, Chief Innovation Officer

Recent News